Morgan Stanley
NFYS.U

Morgan Stanley’s Enphys Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant NFYS.U Stock Holding History

Morgan Stanley’s Portfolio NFYS.U Stock Details NFYS.U Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-40,000
Closed -$390K – 8063
2022
Q1 		$390K Sell
40,000
-40,000
-50% -$395K ﹤0.01% 5556
2021
Q4 		$794K Buy
+80,000
New +$790K ﹤0.01% 5242

Other funds holding NFYS.U

Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
SMA
Sage Mountain Advisors Atlanta, Georgia $1.43B AUM 16.47% 1-Year Est. Return
SFM
Spartan Fund Management Toronto, Ontario, Canada $30M AUM 11.98% 1-Year Est. Return

Morgan Stanley's NFYS.U Position: Q2 2022 in Review

Morgan Stanley sold out of Enphys Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant (NFYS.U) in Q2 2022, closing a stake of 40,000 shares — an estimated $390K sold.

Morgan Stanley first reported a position in NFYS.U in Q4 2021 and held it in 2 quarters. The position peaked at $794K in Q4 2021. 18 funds tracked by Wall St. Rank hold NFYS.U as of Q2 2022.

  • Morgan Stanley reported no remaining Enphys Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant position as of Q2 2022 after selling out during the quarter.
  • Morgan Stanley sold 40,000 Enphys Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant shares in Q2 2022, an estimated $390K.
  • Morgan Stanley first reported a position in Enphys Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant in Q4 2021 and held it in 2 quarters.
  • Morgan Stanley's Enphys Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant position peaked at $794K in Q4 2021.
  • 18 funds tracked by Wall St. Rank held Enphys Acquisition Corp. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant as of Q2 2022.

Based on Morgan Stanley's 13F filing for Q2 2022, filed 15 Aug 2022.